Mirviss Jeffrey B.'s Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 25, 2025
- Accession no.
- 0001225208-25-002386
- Filed
- Feb 25, 2025
- Trade date
- Feb 24-25, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $766.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mirviss Jeffrey B.CIK 0001566094 | Officer (EVP&Pres, Periph Intervent) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | Common Stock | SSaleDisposed | −4,675 | $104.25 | −$487,368.75 | 28,454 | Direct | |
| Feb 25, 2025 | Common Stock | SSaleDisposed | −2,688 | $104.00 | −$279,552 | 25,766 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.